A, M., P, G., L, P., AG, S., M, P., J, S., . . . N, R. (2021). Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data. Frontiers in pharmacology, 12, 729474. https://doi.org/10.3389/fphar.2021.729474
Chicago Style (17th ed.) CitationA, Martínez-Pinteño, et al. "Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data." Frontiers in Pharmacology 12 (2021): 729474. https://doi.org/10.3389/fphar.2021.729474.
MLA (9th ed.) CitationA, Martínez-Pinteño, et al. "Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data." Frontiers in Pharmacology, vol. 12, 2021, p. 729474, https://doi.org/10.3389/fphar.2021.729474.